LEADER 04028nam 2200709Ia 450 001 9910971063603321 005 20251017110111.0 010 $a9780309256971 010 $a0309256976 010 $a9781283636162 010 $a1283636166 010 $a9780309256957 010 $a030925695X 035 $a(CKB)2670000000241222 035 $a(OCoLC)811408123 035 $a(CaPaEBR)ebrary10594219 035 $a(SSID)ssj0000682056 035 $a(PQKBManifestationID)11365573 035 $a(PQKBTitleCode)TC0000682056 035 $a(PQKBWorkID)10663584 035 $a(PQKB)11562092 035 $a(MiAaPQ)EBC3378994 035 $a(Au-PeEL)EBL3378994 035 $a(CaPaEBR)ebr10594219 035 $a(CaONFJC)MIL394862 035 $a(OCoLC)923287600 035 $a(Perlego)4738938 035 $a(DNLM)1595691 035 $a(BIP)53860228 035 $a(BIP)40018774 035 $a(EXLCZ)992670000000241222 100 $a20120723d2012 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aPublic engagement on facilitating access to antiviral medications and information in an influenza pandemic $eworkshop series summary /$fBarbara Fain, Kristin Viswanathan, and Bruce M. Altevogt, rapporteurs ; Forum on Medical and Public Health Preparedness for Catastrophic Events, Board on Health Sciences Policy, Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$d2012 215 $a1 online resource (56 p.) 300 $aBibliographic Level Mode of Issuance: Monograph 311 08$a9780309256940 311 08$a0309256941 320 $aIncludes bibliographical references. 327 $aFrontMatter -- Reviewers -- Contents -- Introduction and Workshop Series Summary -- Appendix: Recruitment Flyer. 330 $aInfluenza pandemics overwhelm health care systems with thousands or hundreds of thousands of sick patients, as well as those worried they may be sick. In order to ensure a successful response to the patient swell caused by a pandemic, robust planning is essential to prepare for challenges public health officials may face. This includes the need to quickly distribute and dispense antiviral medications that can reduce the severity and duration of disease to large numbers of people. In response to a request from the Centers for Disease Control, the Institute of Medicine's Forum on Medical and Public Health Preparedness for Catastrophic Events held a series of workshops that explored the public's perception of how to facilitate access to antiviral medications and treatment during an influenza pandemic. To help inform potential strategies still in the development stages at the CDC, workshops were held in Fort Benton, Montana; Chattanooga, Tennessee; and Los Angeles, California during February and March 2012 to consider the usefulness of several alternative strategies of delivering antiviral medication to the public. Participants considered how the normal systems for prescribing and dispensing antiviral medications could be adjusted to ensure that the public has quick, safe, and equitable access to both potentially life-saving drugs and information about the pandemic and treatment options. This document summarizes the workshops. 517 3 $aAccess to antiviral medications and information in an influenza pandemic 606 $aInfluenza$xPrevention$zUnited States$vCongresses 606 $aAntiviral agents$zUnited States$vCongresses 615 0$aInfluenza$xPrevention 615 0$aAntiviral agents 701 $aFain$b Barbara$01808643 701 $aViswanathan$b Kristin$01808644 701 $aAltevogt$b Bruce M$01791694 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910971063603321 996 $aPublic engagement on facilitating access to antiviral medications and information in an influenza pandemic$94359018 997 $aUNINA